QCLVX
Price
$33.24
Change
+$0.27 (+0.82%)
Updated
Jun 26 closing price
Net Assets
1.71B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
107B
Interact to see
Advertisement

QCLVX vs RMEBX

Header iconQCLVX vs RMEBX Comparison
Open Charts QCLVX vs RMEBXBanner chart's image
Federated Hermes MDT Large Cap Value C
Price$33.24
Change+$0.27 (+0.82%)
VolumeN/A
Net Assets1.71B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets107B
QCLVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCLVX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCLVX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 107B vs. QCLVX (1.71B). RMEBX pays higher dividends than QCLVX: RMEBX (1.16) vs QCLVX (0.20). QCLVX was incepted earlier than RMEBX: QCLVX (8 years) vs RMEBX (11 years). QCLVX (1.92) is less costly to investors than RMEBX (1.07). QCLVX is a more actively managed with annual turnover of: 69.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than QCLVX: RMEBX (250) vs QCLVX (1500). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. QCLVX (3.36). RMEBX return over 5 years is better than : 62.71 vs. QCLVX (42.28).
QCLVXRMEBXQCLVX / RMEBX
Total Expense Ratio1.811.07169%
Annual Report Gross Expense Ratio1.921.07179%
Fund Existence8 years11 years-
Gain YTD6.7727.31593%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B107B2%
Annual Yield % from dividends0.201.1617%
Returns for 1 year3.369.5035%
Returns for 3 years18.6425.8872%
Returns for 5 years42.2862.7167%
Returns for 10 yearsN/A74.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp